FIELD: medicine, vaccines. SUBSTANCE: invention represents vaccine conjugates, immunogenic polypeptides, nucleic acid molecules encoding immunogenic polypeptides, host-cells containing nucleic acid molecules encoding immunogenic polypeptides and methods for preparing vaccine conjugates and immunogenic polypeptides as well as nucleic acid molecules encoding immunogenic polypeptides. Except for, invention represents IgE-vaccine that induces response to "one's own" IgE in mammals. Invention provides reducing effects of IgE antibodies in mammal by decline of total and bound with receptor amount of IgE receptor in mammal. EFFECT: valuable properties of vaccine. 26 cl, 4 dwg, 10 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCTION AND SELECTION OF MOLECULES INCLUDING, AT LEAST TWO DIFFERENT GROUPS, AND APPLICATION THEREOF | 2013 |
|
RU2646159C2 |
METHOD OF TREATMENT OF INFLAMMATORY CONDITIONS BY MEANS OF POLYPEPTIDE CONTAINING OWN AND NONSHARED AMINO-ACID SEGMENTS | 2003 |
|
RU2344144C2 |
PROTEINS BINDING SPECIFIC MEMBRANE PROSTATE ANTIGEN, AND RELATED COMPOSITIONS AND METHODS | 2012 |
|
RU2632647C2 |
POLYPEPTIDES BINDING TO CD3 | 2013 |
|
RU2673153C2 |
HUMAN ANTIBODIES AGAINST SEMAPHORIN 4D | 2018 |
|
RU2776443C2 |
COMPOSITIONS AND METHODS OF TREATING FUNGAL AND BACTERIAL PATHOGENS | 2014 |
|
RU2717306C2 |
HUMANISED ANTIBODY (H14,18) BASED ON MOUSE ANTIBODY 14,18, CONTACTING GD2, AND ITS FUSION WITH IL-2 | 2003 |
|
RU2366664C2 |
FUSED PROTEINS WITH IMMUNOGLOBULIN FC-FRAGMENT FOR ENHANCING IMMUNOGENICITY OF PROTEIN AND PEPTIDE ANTIGENS | 2000 |
|
RU2248214C2 |
PROTEIN COMPLEXES CONTAINING SUPERHELIX AND/OR BANDING, AND THEIR USE | 2010 |
|
RU2573915C2 |
IMMUNOCYTOKINES BASED ON IL-15 AND IL-R[ALPHA] SUSHI DOMAIN | 2012 |
|
RU2644671C2 |
Authors
Dates
2003-10-20—Published
1999-10-21—Filed